Form 4: Hims & Hers Director Granted 3,656 RSUs
Insider Transaction Disclosure
Hims & Hers Health, Inc. director Christopher D. Payne was granted 3,656 Restricted Stock Units, aligning his interests with shareholders.
Summary
- Christopher D. Payne, a Director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs).
- The transaction date for this grant was August 6, 2025.
- Each RSU represents a contingent right to receive one share of Class A Common Stock.
- The RSUs will vest subject to continuous service, on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.
- Following this transaction, Christopher D. Payne beneficially owns 3,656 derivative securities directly.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive as an equity grant to a director generally indicates alignment of interests and retention, which are positive for corporate governance, though it does not directly impact immediate financial performance.
Positives
- The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
- The vesting schedule encourages long-term commitment and continuous service from the director.
Future Outlook
The filing indicates future vesting of granted Restricted Stock Units, contingent on continuous service, which suggests an expectation of continued tenure for the reporting person.
Industry Context
This filing is a standard disclosure of an equity grant to a director, common practice in publicly traded companies across various industries, including the telehealth and wellness sector where Hims & Hers operates. Such grants are part of executive and director compensation packages designed to incentivize performance and retention.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Christopher D. Payne, a Director, received a grant of 3,656 Restricted Stock Units as part of his compensation. | 08/06/2025 | This grant aligns the director's financial interests with long-term shareholder value through equity ownership, promoting good corporate governance. |
Stakeholder Impact
- Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the director's compensation becomes tied to the company's stock performance, potentially encouraging decisions that enhance shareholder value.
Next Steps
- The granted Restricted Stock Units will vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.
Key Dates
| Date | Description |
|---|---|
| 08/06/2025 | Date of RSU grant to Christopher D. Payne. |
| 06/15/2026 | Latest potential vesting date for the granted RSUs, or earlier if the 2026 annual meeting of stockholders occurs before this date. |
| 08/08/2025 | Date the Form 4 filing was signed by the Attorney-in-Fact. |
Keywords
Hims & Hers Health, HIMS, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, SEC Form 4, Equity Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.